维普中文期刊产品整合服务
91篇 您的检索式:作者名="Kunitoh H"
    题名 作者 年代 出处 被引量
1Concurrent daily carboplatin and accelerated hyperfractionnated thoracic radiotherapy in locally advanced non-small-cell lung cancer显示文摘Kunitoh H Watanable K Nagatomo A 1997Int J Radiat Oncol Biol Phys1997,37,:1
2Reasons for response differences seen in the V 15 32 INTEREST and IPASS trials显示文摘Saijo N Takeuchi M Kunitoh H 2009Nat Rey Clin Onco2009,6,5:1
3Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking independent manner in the Japanese 显示文摘Shiraishi K Kohno T Kunitoh H Watanabe S Goto K Nishiwaki Y 2009Carcinogenesis2009,30,1:1
4Randomized,open-label,multicenter phase II sutdy of bevacizumab in combination withcarboplatin and paclitaxel in chemotherapy-naive Japanese pa-tients with advanced or recurrent nonsquamous non-small celllung cancer(NSCLC):JO19907显示文摘Nishio M Horai T Kunitoh H 2009J Clin Oncol2009,2715,:1
5Randomized phase I] study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non- squamous non-small-cell lung cancer 显示文摘Niho S Kunitoh H Nokihara H 2012Lung Cancer2012,76,3:1
6Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae显示文摘Okamoto H Nagatomo A Kunitoh H 1998Cancer Chemother Pharmacol1998,42,4:1
7retrospective a- nalysis of safety and efficacy of low - dose docetaxel 60/m2 inadvanced non - small cell lung cacer patients previously treated with platinum -based chemotherapy 显示文摘Nakamura Y Kunitoh H Kubota K 2007Am J Clin Oncol2007,26,5:1
8Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials显示文摘Sekine I Yamamoto N Kunitoh H 2004Cancer Treatment Reviews2004,30,4:1
9Cancer chemotherapy in the elderly显示文摘Sekine I Fukuda H Kunitoh H 1998Jpn J Clin Oncol1998,28,8:1
10How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer显示文摘Kunitoh H Suzuki K 2007BrJ Cancer2007,96,10:1
11Reasons for response differences seen in the V15-32, INTEREST and IPASS trials显示文摘Saijo N Takeuchi M Kunitoh H 2009Nat Rev Clin Oncol2009,6,5:1
12Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer 显示文摘NIHO S KUNITOH H NOKIHARA H 2012Lung Cancer2012,76,3:1
13Phase I1 trail of docetaxelin previously untlated advanced non-small-cell lung cancer: a Japanese cooperative study显示文摘Kunitoh H Watanabe K Onoshi T 1996J Clin Oncol1996,14,5:1
14Immtmohistochemical KIT( CD117 ) expression in thymic epithelial tumors 显示文摘Nakagawa K Matsuno Y Kunitoh H 2005Chest2005,128,1:1
15Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese显示文摘Shiraishi K Kohno T Kunitoh H 2009Carcinogenesis2009,30,1:1
16Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group显示文摘Kubota K Watanabe K Kunitoh H 2004JClin Oncol2004,22,2:1
17Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae显示文摘Okamoto H Nagatomo A Kunitoh H 1998Cancer Chemother Pharmacol1998,42,4:1
18Reasons for response differ- ences seen in the V15-32, INTERSET and IPASS trials显示文摘Saijo N Takeuchi M Kunitoh H 2009Nat Rev Clin Oncol2009,6,5:1
19Reasons for response differences seen in the V15-32,INTEREST and IPASS trials显示文摘Saijo N Takeuchi M Kunitoh H 2009Nat Rey Clin Oncol2009,6,5:1
20Retrospective analysis of safety and efficacy of low-dose docetaxel 60 mg/m2 in advanced non-small cell lung cancer patients previously treated with platinum-based chemotherapy显示文摘Nakamura Y Kunitoh H Kubota K 2003Am J Clin Oncol2003,26,5:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费